FIGS (FIGS) Stock Forecast & Price Target

FIGS is benefiting from broad-based demand momentum, with 2Q net sales up 28.8% to $197 million, active customers at a record 3.1 million, and net revenues per active customer reaching an all-time high of $229, showing that growth is being driven by both customer acquisition and higher spend. Its product mix and geographic expansion are also improving, as scrubwear still contributed 82% of sales while non-scrubwear rose 40% and international revenue surged 67%, with TEAMS and Community Hubs also setting records. Fundamentally, the company is converting strong brand engagement into profitability, as gross margin expanded to 75.2% and adjusted EBITDA reached $36.6 million, while the balance sheet remains healthy with no debt and management expects 20% top-line growth and 14.8% adjusted EBITDA margin.

FIGS is exposed to macroeconomic weakness, inflation, and other trends that could pressure demand and profitability even though healthcare apparel is relatively resilient in downturns. Its dependence on suppliers and limited manufacturing in China adds cost, political, legal, and supply-chain risk, while higher labor or raw material expenses could compress margins. The bearish case also reflects competitive vulnerability: scrubwear may become commoditized, its style and proprietary fabric advantages can be copied, and its early-stage lifestyle products face entrenched activewear rivals.